Structural basis for coreceptor selectivity by the HIV type 1 V3 loop
- PMID: 17411375
- DOI: 10.1089/aid.2006.0130
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop
Abstract
The third variable region (V3) of the HIV-1 surface glycoprotein, gp120, plays a central role in the interaction of the virus envelope with the cell surface chemokine receptors, triggering membrane fusion and virus entry into human lymphocytes and macrophages. The CXCR4 and CCR5 chemokine receptors are used by "X4-tropic" and "R5-tropic" viruses, respectively. Recently, the crown of the V3 loop was shown to bear a close structural homology to the beta2-beta3 loop in the CXC and CC chemokines, the natural ligands of CXCR4 and CCR5, respectively. This homology can serve as the foundation for 3D molecular modeling of the V3 loops from primary isolates whose coreceptor usage was experimentally defined. The modeling revealed a charged "patch" on the surface of V3 that correlates with coreceptor usage. This V3 surface patch is positively charged in X4-tropic viruses and negatively charged or neutral in R5-tropic viruses, and is formed by two amino acids, at position 11 and at position 24 or 25; amino acids 11 and 24 or 11 and 25 contact each other in 3D space. Residues at positions 11 and 25 were known previously to influence coreceptor usage, and the charge of the residues at these two positions is often used to predict viral tropism. However, we found that the predictive value of using the charge of residues 11, 24, and 25 to identify X4 or R5 tropism was improved over using only the charge of residues 11 and 25. Thus, the data suggest a new " 11/24/25 rule" : a positively charged amino acid at position 11, 24, or 25 defines X4; otherwise R5. This rule gave an overall predictive value of 94% for 217 viruses whose tropism had been determined experimentally as either X4 or R5. The results have additional implications for the design of HIV therapeutics, vaccines, and strategies for monitoring disease progression.
Similar articles
-
Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion.Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):13950-5. doi: 10.1073/pnas.0606312103. Epub 2006 Sep 11. Proc Natl Acad Sci U S A. 2006. PMID: 16966601 Free PMC article.
-
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.J Virol. 2003 Dec;77(24):13376-88. doi: 10.1128/jvi.77.24.13376-13388.2003. J Virol. 2003. PMID: 14645592 Free PMC article.
-
Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.J Virol. 2005 Nov;79(21):13250-61. doi: 10.1128/JVI.79.21.13250-13261.2005. J Virol. 2005. PMID: 16227248 Free PMC article.
-
Genotypic coreceptor analysis.Eur J Med Res. 2007 Oct 15;12(9):453-62. Eur J Med Res. 2007. PMID: 17933727 Review.
-
HIV-1 gp120 V3 loop for structure-based drug design.Curr Protein Pept Sci. 2005 Oct;6(5):413-22. doi: 10.2174/138920305774329359. Curr Protein Pept Sci. 2005. PMID: 16248793 Review.
Cited by
-
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.J Antimicrob Chemother. 2012 Jun;67(6):1479-85. doi: 10.1093/jac/dks055. Epub 2012 Feb 23. J Antimicrob Chemother. 2012. PMID: 22361986 Free PMC article.
-
Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors.J Virol. 2008 Jan;82(2):664-73. doi: 10.1128/JVI.01793-07. Epub 2007 Oct 31. J Virol. 2008. PMID: 17977968 Free PMC article.
-
Forty Years Since the Epidemic: Modern Paradigms in HIV Diagnosis and Treatment.Cureus. 2021 May 2;13(5):e14805. doi: 10.7759/cureus.14805. Cureus. 2021. PMID: 34094761 Free PMC article. Review.
-
The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions.J Virol. 2009 Feb;83(4):1649-59. doi: 10.1128/JVI.02046-08. Epub 2008 Nov 26. J Virol. 2009. PMID: 19036813 Free PMC article.
-
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.AIDS. 2009 Jun 19;23(10):1209-18. doi: 10.1097/QAD.0b013e32832b4399. AIDS. 2009. PMID: 19424056 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources